Universal screening for thyroid disease SHOULD NOT be recommended before and during pregnancy.
miscarriage
pregnancy
premature delivery
screening
thyroid autoimmunity
thyroid hormone
Journal
Best practice & research. Clinical endocrinology & metabolism
ISSN: 1878-1594
Titre abrégé: Best Pract Res Clin Endocrinol Metab
Pays: Netherlands
ID NLM: 101120682
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
6
7
2020
medline:
15
12
2020
entrez:
6
7
2020
Statut:
ppublish
Résumé
Thyroid dysfunction in pregnancy is strongly associated with adverse maternal and foetal outcomes. The effects of treatment are less clear. There is ongoing discussion on whom to treat, when to treat and whether treatment is beneficial. Although universal screening for thyroid disease during pregnancy increases diagnosis and treatment of thyroid dysfunction, there is currently insufficient evidence demonstrating a positive effect of screening on maternal and foetal outcomes. We therefore, at present, recommend against universal screening for thyroid disease before and during pregnancy.
Identifiants
pubmed: 32622828
pii: S1521-690X(20)30056-7
doi: 10.1016/j.beem.2020.101429
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
101429Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.